PEPTONIC medical AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PEPTONIC medical AB - overview
Location
Vaxjo, -, Sweden
Primary Industry
Pharmaceuticals
About
Peptonic Medical AB is an innovative Swedish pharmaceutical company that engages in the development of estrogen-free Pharmaceuticals for the treatment of vaginal atrophy.
Current Investors
ALMI Invest
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.peptonicmedical.se
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
PEPTONIC medical AB - timeline of key events
PEPTONIC medical AB - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 500,000 | - | - | 9,104 | - | - | - | 382,790 | 4,408,484 | 21,283,000 | 31,643,000 | - | - | - |
| % Revenue Growth (YoY) | - | (100.0%) | - | - | (100.0%) | - | - | - | 1051.7% | 382.8% | 48.7% | - | - | - |
| EBITDA (USD) | (4,921,470) | (3,947,549) | (5,663,388) | (10,113,066) | (13,971,116) | (10,250,139) | (12,875,311) | (14,305,675) | (21,067,044) | (27,768,000) | (46,663,000) | - | - | - |
| Operating Income (USD) | (4,930,282) | (3,956,361) | (5,671,472) | (10,115,130) | (13,983,499) | (11,320,163) | (12,961,299) | (14,381,343) | (23,922,426) | (31,053,000) | (73,718,000) | - | - | - |
| Operating Margin | (986.1%) | - | - | (111106.4%) | - | - | - | (3757.0%) | (542.6%) | (145.9%) | (233.0%) | - | - | - |
| % EBITDA Margin | (984.3%) | - | - | (111083.8%) | - | - | - | (3737.2%) | (477.9%) | (130.5%) | (147.5%) | - | - | - |
| NET Income (USD) | (4,898,750) | (3,843,536) | (5,619,012) | (10,097,032) | (13,960,020) | (11,257,772) | (12,972,605) | (14,941,297) | (24,508,950) | (31,092,000) | (73,688,000) | - | - | - |
| % Net Margin | (979.8%) | - | - | (110907.6%) | - | - | - | (3903.3%) | (555.9%) | (146.1%) | (232.9%) | - | - | - |
PEPTONIC medical AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | PEPTONIC medical AB | - |
Displaying 1 - 1 of 1
PEPTONIC medical AB - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.